Merck & Co., Inc.

MRK · Large cap · 1 article

Financial highlights

Metric	FY 12/31/25	FY 12/31/24	FY 12/31/23	FY 12/31/22	FY 12/31/21
Income Statement
Revenue	$65.0B	$64.2B	$60.1B	$59.3B	$48.7B
Cost of revenue	$16.4B	$15.2B	$16.1B	$17.4B	$13.6B
Selling, general & administrative	$10.7B	$10.8B	$10.5B	$10.0B	$9.6B
Research and development	$15.8B	$17.9B	$30.5B	$13.5B	$12.2B
Interest expense	$1.4B	$1.3B	$1.1B	$962.0M	$806.0M
Pretax income	$21.1B	$19.9B	$1.9B	$16.4B	$13.9B
Income tax expense	$2.8B	$2.8B	$1.5B	$1.9B	$1.5B
Net income	$18.3B	$17.1B	$365.0M	$14.5B	$13.0B
Balance Sheet
Cash and equivalents	$14.6B	$13.2B	$6.8B	$12.7B	$8.1B
Current assets	$43.5B	$38.8B	$32.2B	$35.7B	$30.3B
Total assets	$136.9B	$117.1B	$106.7B	$109.2B	$105.7B
Current liabilities	$28.3B	$28.4B	$25.7B	$24.2B	$23.9B
Total debt	$49.3B	$37.1B	$35.1B	$30.7B	$33.1B
Stockholders' equity	$52.6B	$46.3B	$37.6B	$46.0B	$38.2B
Cash Flow Statement
Cash from operations	$16.5B	$21.5B	$13.0B	$19.1B	$13.1B
Depreciation and amortization	$3.0B	$2.1B	$1.8B	$1.8B	$1.6B
Stock-based compensation	$820.0M	$761.0M	$645.0M	$541.0M	$479.0M
Capital expenditure	$4.1B	$3.4B	$3.9B	$4.4B	$4.4B
Free cash flow	$12.4B	$18.1B	$9.1B	$14.7B	$8.7B
Dividends paid	$8.2B	$7.8B	$7.4B	$7.0B	$6.6B
Share repurchases	$5.1B	$1.3B	$1.3B	$0	$840.0M
Impairments	—	—	—	$1.7B	—

Shares outstanding 2.5B · Free float 99.4%

Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.